Leo Laboratories Limited

Longwick Road, Princes Risborough, Bucks., HP27 9RR
Telephone: +44 (0)1844 347 333
Fax: +44 (0)1844 276 385
Medical Information e-mail: medical-info.uk@leo-pharma.com
Summary of Product Characteristics last updated on the eMC: 16/05/2006
SPC Burinex 5mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/05/2006 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 6.1 - List of Excipients
  • Change from BAN to rINN
Date of revision of text on the SPC:   31/12/05
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.2, Posology and method of administration: Frusemide amended to furosemide.
Section 6.1, List of excipients: Polyvidone amended to povidone
Updated on 17/08/2001 and displayed until 16/05/2006
Reasons for adding or updating:
  • Change from datasheet to SPC

Active Ingredients/Generics

 
   bumetanide


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk